NovaRad has recently received U.S. Food and Drug Administration (FDA)clearance for reading and interpreting mammography studies for its NovaPACS which is used for the distribution and viewing of mammography studies, including window,level,zoom and volumetric measurements.
Related Content
News | Women's Health
Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...
December 17, 2025 
News | Breast Imaging
Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...
December 16, 2025 
News | FDA
Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...
December 08, 2025 
News | Breast Imaging
Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...
December 04, 2025 
News | Women's Health
Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...
December 02, 2025 
News | RSNA 2025
Nov. 27, 2025— AdvaHealth Solutions is highlighting AdvaPACS, its cloud-native and AI-forward imaging platform at RSNA ...
November 29, 2025 
News | Artificial Intelligence
Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...
November 07, 2025 
News | Breast Imaging
Oct. 28, 2025 — QT Imaging Holdings, Inc., a medical device company focused on radiation-free imaging technology, has ...
October 28, 2025 
Feature | Breast Imaging
Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...
October 24, 2025 
News | Digital Pathology
Aug. 12, 2025 — Fujifilm Healthcare Americas Corp. has announced that a leading health system with hospital sites ...
August 12, 2025 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now